Comparative Effects of Aspirin, Metformin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease
Clinical trial NCT07338331 · COMPLETED
Trial details
- NCT number
- NCT07338331
- Sponsor
- Galala University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-04
- Primary completion
- 2025-04-05
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.